Choosing between antipsychotics to reduce the risk of breast cancer in women with schizophrenia

angiola-harry-nJv6xnlpNaA-unsplash

Peter Knapp and Suzy Ker review a recent study from Finland, which suggests that women with schizophrenia who take prolactin-increasing antipsychotics for at least five years, have an increased risk of developing breast cancer.

[read the full story...]